Ichor Life Sciences Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$1.71M
- Investors
-
9
Ichor Life Sciences General Information
Description
Developer of a biotechnology platform designed to research therapeutic interventions for age-related diseases. The company's platform develops and commercializes research and clinical products in the field of regenerative medicine, enabling healthcare professionals to access safe and effective aging therapies.
Contact Information
Website
www.ichorlifesciences.comCorporate Office
- 831 James Street
- Syracuse, NY 13203
- United States
Corporate Office
- 831 James Street
- Syracuse, NY 13203
- United States
Ichor Life Sciences Timeline
Ichor Life Sciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
14. Debt - General | 12-Sep-2024 | $1.71M | Completed | Generating Revenue | ||
13. Accelerator/Incubator | 01-Apr-2022 | Completed | Generating Revenue | |||
12. Later Stage VC | 01-Mar-2019 | Completed | Generating Revenue | |||
11. Early Stage VC (Series A) | 29-Dec-2017 | Completed | Generating Revenue | |||
10. Seed Round | 30-May-2017 | Completed | Generating Revenue | |||
9. Seed Round | 02-Mar-2016 | Completed | Generating Revenue | |||
8. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
7. Grant | 07-Jul-2015 | Completed | Pre-Clinical Trials | |||
6. Grant | 01-Feb-2015 | $25K | $550K | Completed | Pre-Clinical Trials | |
5. Product Crowdfunding | 02-Nov-2014 | $6.97K | $550K | Completed | Pre-Clinical Trials |
Ichor Life Sciences Patents
Ichor Life Sciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10813981-B2 | Saposin b binds the lipofuscin bisretinoid a2e and prevents its enzymatic and photo degradation | Active | 03-Feb-2017 | ||
US-20180221455-A1 | Saposin b binds the lipofuscin bisretinoid a2e and prevents its enzymatic and photo degradation | Active | 03-Feb-2017 |
Ichor Life Sciences Signals
Ichor Life Sciences Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Science Foundation | Government | |||
Kizoo Technology Capital | Venture Capital | Minority | ||
SENS Research Foundation | Limited Partner | Minority | ||
Methuselah Foundation | Not-For-Profit Venture Capital | |||
CenterState CEO | Government |
Ichor Life Sciences Investments & Acquisitions (4)
Ichor Life Sciences’s most recent deal was a Seed Round with Cypris Therapeutics for . The deal was made on 24-Jun-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Cypris Therapeutics | 24-Jun-2024 | Seed Round | Biotechnology | ||
Lento Bio | 06-Sep-2022 | Seed Round | Drug Discovery | ||
MitoChem Therapeutics | 15-Aug-2022 | Corporate | Biotechnology | ||
Woodland Biosciences | 01-Sep-2021 | Merger/Acquisition | Other Healthcare Services |
Ichor Life Sciences Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Grapeseed.Bio | Accelerator/Incubator | New York, NY |
Ichor Life Sciences FAQs
-
When was Ichor Life Sciences founded?
Ichor Life Sciences was founded in 2013.
-
Where is Ichor Life Sciences headquartered?
Ichor Life Sciences is headquartered in Syracuse, NY.
-
What is the size of Ichor Life Sciences?
Ichor Life Sciences has 37 total employees.
-
What industry is Ichor Life Sciences in?
Ichor Life Sciences’s primary industry is Biotechnology.
-
Is Ichor Life Sciences a private or public company?
Ichor Life Sciences is a Private company.
-
What is Ichor Life Sciences’s current revenue?
The current revenue for Ichor Life Sciences is
. -
How much funding has Ichor Life Sciences raised over time?
Ichor Life Sciences has raised $8.11M.
-
Who are Ichor Life Sciences’s investors?
National Science Foundation, Kizoo Technology Capital, SENS Research Foundation, Methuselah Foundation, and CenterState CEO are 5 of 9 investors who have invested in Ichor Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »